Navigation Links
Sheer exhaustion makes a junior doc’ kill a patient!

According to an inquest heard, a patient was given a lethal overdose of insulin by a tired junior doctor, after working more than 100 hours in a week.//

Dr Helen Pike, 30, gave the injection herself, in spite of 2 nurses warning her. The patient, Tony Wright, 58 suffered a massive cardiac arrest just a few minutes later. 10 days later, he passed away in the hospital’s ICU.

Once his wife heard about the gruelling work schedule of Dr.Pike, she did not hold Dr.Pike responsible for what happened.

During the hearing at Leeds Coroners' Court, Freda Wright, 71, told the hospital doctor: "I would just like to say that we do not attach any blame to you. You did your best." The tragedy shows how inadequate rest and long work hours affect junior doctors while taking life and death decisions.

Michael Summers of the Patients' Association said: "Junior doctors work very, very long hours. With such a high bed-occupancy in hospitals, doctors are working extremely hard and on occasions longer hours than is acceptable, the problem is mistakes will be made as a result of those pressures.

"The rules are there but they are not necessarily being adhered to."

The tragedy happened in December 2003. Dr Pike was supposed to have been working six 13-hour shifts, but as a result of working extra hours and exchanging shifts with colleagues she worked for more than 100 hours in seven days during that time.

Most of the short naps were in the hospital staff room and usually interrupted by calls for her to return to the wards.

Dr Pike was a senior house officer at Leeds General Infirmary during that time. According to her police statement, she had been worried about the worsening of Mr Wright's condition after an artery bypass operation and she had tried to get him admitted to a high dependency unit.

The amount of potassium in his blood had increased to fatal levels and it were decided to give him insulin
'"/>




Page: 1 2 3

Related medicine news :

1. What makes young girls smoke
2. Eating chocolate makes you happy
3. Self control makes stress response easy
4. Useful device makes spinal surgery safer
5. Likely reason which makes analgesics work against Alzheimers
6. Right attitude makes you benefit from exercise
7. Virus makes Hodgkin’s disease more deadl
8. Co-infection of Two genetic diseases makes them susceptible to malaria
9. Bird flu makes its presence felt in the Crimean peninsula
10. A strategic study: Soy diet makes heart disease to worsen in male mice
11. Crackdown on drugs makes African students insecure
Post Your Comments:
(Date:9/5/2008)...odels are enhanced by taking into account risk fac... according to research teams led by epidemiologist... Center in two complementary papers appearing in t.... , In the first study to focus on African-Ameri...creased exposure to certain risks. Based upon thes...
(Date:9/4/2008)...e Medicare Advantage (MA) plans will be paid an av...red to what the same enrollee would have cost in t...ccording to a new report from The Commonwealth Fun...dated by the Medicare Improvements for Patients an... effect beginning in 2010 had been fully in place...
(Date:9/4/2008)...pancreatic tumors , , THURSDAY, Sept. 4 ...coveries involving genetic mutations of two deadly...reatic cancer -- may lead to new treatments and ev...present the most complete genetic analysis to date...map of these deadly cancers," Kenneth Kinzler, a p...
(Date:9/4/2008)...RNewswire/ -- Martin Schiff, M.D.,is an illustriou...weight,control and weight loss. His career is deta...he West," "Who,s Who in America," "Who,s Who in,th...and other honor rolls., Dr. Schiff recently retir...ate, misleading theories and notions concerning we...
Breaking Medicine News(10 mins):Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3Health News:Extra payments to Medicare Advantage plans to total $8.5 billion in 2008 2Health News:Genetic Mutations Linked to Deadly Cancers 2Health News:Genetic Mutations Linked to Deadly Cancers 3Health News:Genetic Mutations Linked to Deadly Cancers 4Health News:Phone World-famed Martin Schiff, M.D., at 310-454-6172 for Free Weight Loss 'No Diet, No Stuff' Method. Hates Diets, Loves to Have People Help Themselves 2
...alyzing the neuronal receptor activity in the post...ia, researchers at the University of Pennsylvania ...ists at the City University of New York, have foun...h level of erbB4 receptor activity and reduced NMD...
...a of subjecting drug addicts to shock therapy as a... debates and controversies. Now, the Scottish Exec...rapy //. Shock therapy technically labeled as Neu...with the use of self-adhesive electrodes inserted ...
...bane childcare center, a tuberculosis case alerts ...diagnosed in a childcare worker, who works at the ...Mount Ommaney in west Brisbane. Dr Michael Whitby... Medical Association (AMA) said that children’s (m...
...ast Victoria Sale Hospital's two pediatricians, Jo...ions with three months notice with three months no...xpected for at least six months. This has led to .... Sale obstetrician Dr Refaat Guirguis has said th...
Other Medicine News:Health News:Schizophrenia Complicates With Altered Receptor Activity 2Health News:Schizophrenia Complicates With Altered Receptor Activity 3
(Date:9/5/2008)... SOUTH SAN FRANCISCO, Calif., Sept. 5 /PRNewswir...pany focused on small molecule LFA-1 inhibitors,to...uticals, Inc. (Nasdaq:,SNSS) today announced SARco...mall molecule LFA-1 product candidate for T-cell m...ntered into a license agreement providing,SARcode ...
(Date:9/4/2008)... MELBOURNE, Australia, Sept. 4 /- C...is commencing enrolment for its Phase Ib/II,study ... anticancer agent,in patients with an aggressive ...rme (GBM)., The GBM clinical trial is the first P...umor indications for the company and the second in...
(Date:9/4/2008)...Another Roche first in TaqMan(R) real-time PCR tes... lab, PLEASANTON, Calif., Sept. 4 /PRNewswi...as approved the Roche COBAS(R) TaqMan(R) HBV Test,...s DNA approved in the U.S.,The test uses Roche,s r...Hepatitis B virus DNA in a patient,s blood. Doctor...
(Date:9/4/2008)... BIRMINGHAM, Ala., Sept. 4 /- South...tional Institutes of Health (NIH) has selected,the...olecular Libraries,Probe Production Center Network...twork -- is part of the Molecular Libraries Progra...en scientific knowledge of the human,genome and va...
Breaking Medicine Technology:SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Kaiser Permanente CEO Receives Diversity Leadership Award 5201 1Kaiser Permanente CEO Receives Diversity Leadership Award 5201 2United Therapeutics Reports Third Quarter 2007 Financial Results 1642 1United Therapeutics Reports Third Quarter 2007 Financial Results 1642 2United Therapeutics Reports Third Quarter 2007 Financial Results 1642 3United Therapeutics Reports Third Quarter 2007 Financial Results 1642 4United Therapeutics Reports Third Quarter 2007 Financial Results 1642 5United Therapeutics Reports Third Quarter 2007 Financial Results 1642 6United Therapeutics Reports Third Quarter 2007 Financial Results 1642 7United Therapeutics Reports Third Quarter 2007 Financial Results 1642 8United Therapeutics Reports Third Quarter 2007 Financial Results 1642 9Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes 1637 1Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes 1637 2Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes 1637 3Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes 1637 4Triumph 1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint 5194 1Triumph 1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint 5194 2Triumph 1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint 5194 3Triumph 1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint 5194 4Triumph 1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint 5194 5Triumph 1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint 5194 6
...WIRE) -- June 14,2007 -- Targeted Genetics Corpor...the dose escalation arm of the ongoing Phase,I/II ...atory,arthritis. Philip J. Mease, M.D., clinical p... Medicine, chief of rheumatology,clinical research...an with Seattle Rheumatology Associates and the le...
...- Prolexys,Pharmaceuticals and announced today a p...ive small molecule anti-tumor agent,erastin. Prol...eomics technology to understand the mechanism of a...the June 14, 2007 issue,of the journal Nature reve...pendent anion channels (VDACs) -- a novel target f...
Other Medicine Technology:Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 2Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 3Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 4Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 5Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 6Prolexys Pharmaceuticals and Columbia University Researchers,Publish Study on Anti-Tumor Properties of a Selective Small,Molecule Anti-Tumor Agent With Novel Mechanism of Action 2Prolexys Pharmaceuticals and Columbia University Researchers,Publish Study on Anti-Tumor Properties of a Selective Small,Molecule Anti-Tumor Agent With Novel Mechanism of Action 3
Delicate side cutting wire cutter with carbide inserts.
Curved osteotome for bone removing.
...t. It is created using the Panoramic200 and is use...ye and non-eye diseases and disorders. It is avail... non-reimbursable. The optomap provides the practi...tients retina which is viewed on-screen by the pra...
...amera is a state-of-the-art, office-based nuclear ...riendly gantry, and provides full sized fields of ...linic you need a flexible system that can work aro... Pulse reduces the costs of adding a gamma camera ...
Medicine Products: